CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan
· Delayed Price · Currency is TWD 95.10
-0.10 (-0.11%)
Aug 15, 2025, 1:30 PM CST
CH Biotech R&D Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 9,776 | 8,306 | 8,275 | 7,320 | 5,150 | 4,263 | Upgrade
|
| Market Cap Growth | -7.53% | 0.37% | 13.05% | 42.15% | 20.79% | -25.79% | Upgrade
|
| Enterprise Value | 10,042 | 8,439 | 8,371 | 7,556 | 5,884 | 5,151 | Upgrade
|
| Last Close Price | 95.10 | 77.31 | 73.91 | 65.21 | 44.98 | 36.88 | Upgrade
|
| PE Ratio | 26.97 | 17.44 | 17.86 | 15.73 | 17.67 | 42.56 | Upgrade
|
| PS Ratio | 5.80 | 5.08 | 5.46 | 5.10 | 5.06 | 6.07 | Upgrade
|
| PB Ratio | 3.65 | 3.14 | 3.28 | 3.51 | 2.99 | 2.88 | Upgrade
|
| P/TBV Ratio | 3.66 | 3.15 | 3.29 | 3.52 | 3.00 | 2.90 | Upgrade
|
| P/FCF Ratio | 59.49 | - | 15.17 | 12.51 | 26.76 | 34.10 | Upgrade
|
| P/OCF Ratio | 29.97 | 15.43 | 12.56 | 10.47 | 19.48 | 18.30 | Upgrade
|
| EV/Sales Ratio | 5.96 | 5.16 | 5.53 | 5.27 | 5.78 | 7.34 | Upgrade
|
| EV/EBITDA Ratio | 13.72 | 11.97 | 11.90 | 12.03 | 13.50 | 23.02 | Upgrade
|
| EV/EBIT Ratio | 18.93 | 15.56 | 14.79 | 14.78 | 16.38 | 35.51 | Upgrade
|
| EV/FCF Ratio | 61.11 | - | 15.35 | 12.91 | 30.58 | 41.20 | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.28 | 0.34 | 0.43 | 0.65 | 0.88 | Upgrade
|
| Debt / EBITDA Ratio | 1.22 | 1.02 | 1.16 | 1.38 | 2.47 | 5.39 | Upgrade
|
| Debt / FCF Ratio | 5.43 | - | 1.55 | 1.53 | 5.83 | 10.42 | Upgrade
|
| Asset Turnover | 0.44 | 0.45 | 0.44 | 0.46 | 0.35 | 0.25 | Upgrade
|
| Inventory Turnover | 3.93 | 2.25 | 1.72 | 1.98 | 2.04 | 2.28 | Upgrade
|
| Quick Ratio | 1.04 | 1.08 | 1.24 | 1.30 | 0.98 | 0.86 | Upgrade
|
| Current Ratio | 1.22 | 1.32 | 1.40 | 1.72 | 1.24 | 0.98 | Upgrade
|
| Return on Equity (ROE) | 13.36% | 18.41% | 20.11% | 24.43% | 18.20% | 6.77% | Upgrade
|
| Return on Assets (ROA) | 8.68% | 9.31% | 10.33% | 10.26% | 7.60% | 3.20% | Upgrade
|
| Return on Capital (ROIC) | 9.34% | 10.03% | 11.14% | 10.96% | 7.98% | 3.31% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.20% | 18.20% | 20.50% | 18.70% | 14.40% | 6.00% | Upgrade
|
| Earnings Yield | 3.73% | 5.73% | 5.60% | 6.36% | 5.66% | 2.35% | Upgrade
|
| FCF Yield | 1.68% | -0.60% | 6.59% | 7.99% | 3.74% | 2.93% | Upgrade
|
| Dividend Yield | 4.31% | 5.30% | 5.53% | 5.95% | 2.90% | 1.18% | Upgrade
|
| Payout Ratio | 115.69% | 77.47% | 102.26% | 27.21% | 14.48% | 88.30% | Upgrade
|
| Buyback Yield / Dilution | -3.07% | -5.50% | 0.77% | -0.54% | -0.44% | 0.37% | Upgrade
|
| Total Shareholder Return | 1.23% | -0.20% | 6.31% | 5.41% | 2.46% | 1.55% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.